Pavel Mozgunov
@pmozgunov
Group Leader @MRC_BSU & NIHR Fellow working on bringing efficient adaptive clinical trial designs to practice
ID:855536531150446596
21-04-2017 21:39:38
368 Tweets
482 Followers
250 Following
📢 Our short course on Efficient Adaptive Designs for Phase I Dose-Escalation Studies is back!
24 - 26 June, Cambridge
Led by Pavel Mozgunov & Thomas Jaki (he/him) 🇪🇺
More info & registration 👇
onlinesales.admin.cam.ac.uk/conferences-an…
Just after the excitement and thrilled of our 20th Armitage lecture and workshop, please save the date for another event with a fantastic line-up of international speakers visiting the Cambridge campus MRC Biostatistics Unit
JOB: Research Associate/Assistant in Medical Statistics. I am hiring (yes, more!). Join our team MRC Biostatistics Unit to work on developing state-of-the-art dose-escalation designs jobs.cam.ac.uk/job/43805/
I am looking for a post-doctoral research associate to work with me Uni Regensburg on heterogeneity in treatment effects with application to alcohol use disorder. Full details are here: uni-regensburg.de/assets/univers…
Great PhD opportunities at MRC Biostatistics Unit! This includes one project with me on sequence of early phase trials!
This workshop is a part of my Advanced NIHR NIHR Research Fellowship focusing on bridging the gap between the theory of adaptive designs and practice. Join us! Either in person (see Cambridge outside of tourist season) or online.
Our short course on Adaptive Designs in Clinical Research introduces adaptive designs and its most common types.
Led by experts; Pavel Mozgunov, Thomas Jaki (he/him) 🇪🇺, Sofia S. Villar, Martin Law & David Robertson.
30 Oct-1 Nov, Cambridge
Register here:
onlinesales.admin.cam.ac.uk/conferences-an…
All the best to our 11 interns who we’ve been lucky to have around for the 2023 edition of the MRC Biostatistics Unit internship programme! If you are (or know someone who is) looking for a first research experience in biomedical statistics, stay tuned the next call will be announced shortly!
Join Thomas Jaki (he/him) 🇪🇺 and me in September to learn about state-of-the-art dose-escalation designs. The course is built around the real trials that we have been involved in over the past few years.